Is Memantine legal in Belgium?

Legal status

Memantine is not a named controlled drug in Belgium, and the position that applies to it is a medicines or product one. The check found no controlled drug entry; the position is a medicines one, with the official Belgian medicine database listing authorised memantine products including Ebixa and recording a specialist first prescription route with general practitioner follow up. The prescribing arrangement recorded here is a medicines rule about who may start the treatment, and it is not a schedule placement. The controlled drug lists in the Royal Decree of 6 September 2017 do not reach it, and under the delegated model a substance outside the list the King has settled is not governed by article 2bis of the Law of 24 February 1921 at all. That is a statement about the drug decree only, and it does not make the substance unregulated.

Consequences if caught

Capital exposure: none. Belgium's drug law carries no death penalty and no life sentence. On this row no controlled drug ladder attaches either. Article 2bis of the Law of 24 February 1921 reaches substances the King has listed, and memantine is not on that list, so it supplies no band, no aggravated ceiling and no fine on this row. Separate product, food, tobacco, alcohol, medicines or veterinary penalties sit outside this row unless it states one, and it states none. Here the medicines regime supplies the rule and the drug decree does not. Supplying a prescription only medicine outside the medicines rules remains an offence under those rules, which this row does not set out.

If prescribed or medical

The rule that applies to a traveller here is Belgium's own and it is one rule for the whole country: article 3(4)(4) of the Royal Decree of 6 September 2017. It is a document exception rather than a schedule, and it is not a prescribing right. It covers a medicine that was lawfully obtained, carried for the traveller's own personal use, and limited to no more than three months of treatment, and it expressly excludes the substances in Annex II limb A. Memantine is not in Annexes I to IV at all on this row's finding, so there is nothing here for the exception to except, and a travel question about it is a medicines or product question rather than a controlled drug one. The first prescription arrangement recorded for Belgium is about starting treatment inside Belgium and is not the traveller document exception. No route specific to memantine was found in this dossier and none has been invented for it.

Documentation

Carry the prescription and the original dispensing packaging as you would for any prescribed medicine, and be aware that Belgium records a specialist first prescription route with general practitioner follow up for this one. The medicines position was read on 18 September 2026. The annex text read is the non official consolidated version published by the AFMPS; it is informative and the Moniteur belge controls. The annex consolidation relied on here is valid from 29 March 2026, following the amending Royal Decree published on 19 March 2026, and carries a correction dated 16 July 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Belgium’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.